Glass Half Full for Bayer
622596
Bayer (NYSE: BAY) is the latest company to find itself in hot water over a drug recall. But as the company gears up to burnish its image, the improvement in its financial performance promises
246773
A drug developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in some liver cancer patients in a mid-stage trial and stabilized the disease, the companies said Wednesday.
526441
German chemicals and pharmaceuticals giant Bayer said that its agrochemicals division, CropScience, was being sued by rice farmers in the United States in a fight over genetically modified long-grain rice.
285978
German chemical and drug maker Bayer AG said Thursday that it will sell its HC Starck division to private-equity firms Advent International and The Carlyle Group for more than $900 million in cash.
722341
German drugs and chemicals group  Bayer  said it planned to sell unit H.C. Starck to a  consortium formed by Advent International and the Carlyle Group  for 700 million euros ($908 million) plus debt.
285531
A drug being developed by Bayer AG and  Onyx Pharmaceuticals shrank tumors in 9 percent of liver cancer  patients in a mid-stage clinical trial, the companies said on  Wednesday.
2932
According to fdi.gov.cn: According to Germany-based Bayer Group, it has laid down a latest investment plan for 2009 in China. The plan will enable 1.8 billion euro of additional investment in Bayer's new synthetic material production project in Shanghai.
59572
Bayer, the German chemicals and pharmaceuticals giant, said on Friday that it planned to slash 6,100 jobs worldwide as part of the integration of newly-acquired drug maker Schering.
738382
The drug maker is poised to speed past its rivals.
439835
The Schering-Plough Corp. will market and distribute Bayer AG&#39;s primary care pharmaceutical products in the United States under an agreement announced Monday that could impact up to 1,800 jobs.
536231
Investors in Germany's Bayer will get  one share in chemicals and polymers spin-off Lanxess for every  10 Bayer shares held, a German newspaper said, valuing Lanxess  at nearly 1.6 billion euros ($1.97 billion).
511685
German drugs and chemicals group   Bayer BAYG.DE has received bids for its H.C. Starck chemicals   unit that are well above 1 billion euros ($1.3 billion),   industry sources told Reuters on Wednesday.
48286
LONDON, September 13 (New Ratings) - Analyst Norbert Barth of DZ Bank maintains his &quot;buy&quot; rating on Bayer (BAY.ETR). The fair value is set to â¬25.
6332
Drug maker Bayer was slow to report the risks of its cholesterol-lowering drug Baycol and to remove it from the market in 2001, according to an forthcoming report in the Journal of the American Medical Association.
263858
In a move that could lead to a criminal investigation, the government is checking its records to determine if drug maker Bayer AG was forthcoming about safety concerns with
151021
In an Aug. 31 story on Bayer AG's quarterly earnings, The Associated Press reported erroneously that the German drug and chemical company acquired U.S. group Lyondell Chemical.
326217
Bayer unveiled a mixed set of second-quarter results, with operating profit beating analysts' expectations although bottom-line earnings stagnated and the pharmaceuticals division continued to cause headaches for the German maker of Aspirin.